Information & explanations, latest texts & monographs on
Mental_illness (including recent related patents.)
Mental illnessA mental illness is a psychiatric disorder that results in a disruption in a person's thinking, feeling, moods, and ability to relate to others. Psychiatrists generally attribute mental illness to organic/neurochemical causes that can be treated with psychiatric medication, psychotherapy, lifestyle adjustments and other supportive measures. Compare rational-emotive therapy. Mental illness is distinct from the legal concept of insanity. Mental health, mental hygiene and mental wellness are all terms used to describe the absence of mental illness. Advocacy organizations have been trying to change the common perception of psychiatric disorders as a sign of personal weakness and something to be ashamed of to an affliction akin to physical diseases (like the measles). Table of contents showTocToggle("show","hide") 1 Prevalence of and diagnosis of mental illness 2 Controversy over the nature of mental illness 3 Categorization of mental illness 4 Symptoms of mental illness 5 See also 6 External links Prevalence of and diagnosis of mental illness According to the President's New Freedom Commission on Mental Health, major mental illness, including major depression, bipolar disorder, schizophrenia, and obsessive-compulsive disorder, when compared with all other diseases (such as cancer and heart disease), is the most common cause of disability in the United States. According to NAMI (the National Alliance for the Mentally Ill) an American advocacy organisation, twenty-three percent of North American adults will suffer from a clinically diagnosable mental illness in a given year, but less than half of them will suffer symptoms severe enough to disrupt their daily functioning. Approximately nine percent to 13 percent of children under the age of 18 experience a serious emotional disturbance with substantial functional impairment, and five percent to nine percent have a serious emotional disturbance with extreme functional impairment due to a mental illness. Many of these young people will recover from their illnesses before reaching adulthood, and go on to lead normal lives uncomplicated by illness. The treatment success rate for a first episode of schizophrenia is 60 percent, 65 percent to 70 percent for major depression, and 80 percent for bipolar disorder. At the start of the 20th century there were only a dozen recognized mental illnesses. By 1952 there were 192 and the DSM-IV today lists 374. Depending on your perspective this could be seen to be
This article is adapted from from Wikipedia All Wikipedia article text is available under the terms of the GNU Free Documentation License Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision) by Task Force on DSM-IV Stop Walking on Eggshells; Coping When Someone You Care about Has Borderline Personality Disorder by Paul T. Mason The Bipolar Child: The Definitive and Reassuring Guide to Childhood's Most Misunderstood Disorder (Revised and Expanded Edition) by M.D. Demitri Papolos Waking the Tiger : Healing Trauma : The Innate Capacity to Transform Overwhelming Experiences by Peter A. Levine Trauma and Recovery by Judith Herman MD Quick Reference to the Diagnostic Criteria from DSM-IV-TR by American Psychiatric Association Asperger's Syndrome: A Guide for Parents and Professionals by Tony Attwood Change Your Brain, Change Your Life: The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiven by M.D. Daniel G. Amen Heal Your Body: The Mental Causes for Physical Illness and the Metaphysical Way to Overcome Them/102A by Louise L. Hay I DONT WANT TO TALK ABOUT IT: OVERCOMING THE SECRET LEGACY OF MALE DEPRESSION by Terrence Real TOUCHED WITH FIRE: Manic Depressive Illness and the Artistic Temperament by Kay Redfield Jamison Lost in the Mirror: An Inside Look at Borderline Personality Disorder by Richard A. Moskovitz M.D. New Hope for People with Bipolar Disorder : Your Friendly, Authoritative Guide to the Latest in Traditional and Complementary Solutions, Including: Prope by Jan Fawcett The Stop Walking on Eggshells Workbook: Practical Strategies for Living With Someone Who Has Borderline Personality Disorder by Randi Kreger Desk Reference to the Diagnostic Criteria From DSM-IV-TR by American Psychiatric Association Recent Mental_illness related patents From USPTO: 6713479: Piperidine-piperazine ligands for neurotransmitter receptors 6703383: Antipsychotic sulfonamide-heterocycles, and methods of use thereof 6699879: Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists 6696457: Morphinoid compounds 6673596: In vivo biosensor apparatus and method of use 6664229: Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72 6656953: 4,4-Disubstituted piperidines, and methods of use thereof 6653464: Methods and compositions for screening for human Borna disease virus 6649345: Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders 6627625: Treatment of behavioral disorders with .beta.-lactam compounds 6622036: Method for classifying and treating physiologic brain imbalances using quantitative EEG 6579899: Composition for treatment of stress 6576260: Sustained-release form of administration containing tramadol saccharinate 6569403: Determining effects of external stimuli on the brain using PET 6563015: Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof 6552087: Therapeutic agent comprising (+)-sibutramine 6548271: Nucleic acids encoding human transporter proteins 6544559: Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles 6540674: System and method for supervising people with mental disorders 6534514: Kappa opioid receptor antagonists 6527712: Auditing public health 6518314: Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions 6509190: DNA regulatory element for the expression of transgenes in neurons of the mouse forebrain 6500824: Kappa (OP2) opioid receptor antagonists 6489319: Neurotherapeutic use of carboxypeptidase inhibitors 6488953: Oral transmucosal delivery 6484144: Method and system for healthcare treatment planning and assessment 6479725: Method of treatment of a wound or incision 6470298: Apparatus and method for probabilistic population size and overlap determination 6469064: Materials and methods for the treatment of depression 6468973: Method in the treatment of schizophrenia 6458080: Managing parameters effecting the comprehensive health of a user 6455521: Condensed thiophene compounds and pharmaceutical use thereof 6436959: 4-[aryl(piperidin-4-yl)]aminobenzamides 6413940: Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS 6410529: Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists 6406439: Phase lock evoked response audiometer 6368632: Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles 6365594: Heterocycle-condensed morphinoid derivatives (II) 6362173: Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists 6344342: Human G protein coupled lysophosphatidic acid receptor 6337207: Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon 6335168: Alleles of the human mu opioid receptor and diagnostic methods based thereon 6322503: Method of diagnosing, tracking, and treating depression 6321105: Method for diagnosing neurological, neurodegenerative and psychiatric diseases by magnetic resonance imaging using contrast agents with high magnetic susceptibility and extended plasma half life 6294583: Methods of treating tardive dyskinesia and other movement disorders 6284799: Cancer treatment 6271239: Delta opioid receptor-selective benzylidene-substituted morphinans 6271225: Fused thiophene compounds and medicinal use thereof |